Display options
Share it on

Bioanalysis. 2015 Sep;7(18):2297-2309. doi: 10.4155/bio.15.119. Epub 2015 Jun 24.

Simultaneous and stereospecific analysis of warfarin oxidative metabolism using 2D LC/Q-TOF.

Bioanalysis

Siji Joseph, Murali Subramanian, Smriti Khera

Affiliations

  1. Life Science Center, Agilent Technologies, Inc., Bangalore 560048, India.
  2. Pharmaceutical Candidate Optimization, Biocon Bristol-Myers Squibb Research & Development Center, Syngene International Limited, Bangalore 560100, India.
  3. Life Science Group, Agilent Technologies, Inc., Santa Clara, CA 95080, USA.

PMID: 26105112 DOI: 10.4155/bio.15.119

Abstract

BACKGROUND: Warfarin is a widely used racemic anticoagulant with narrow therapeutic range and wide interindividual response to treatment. This is due to the extensive and differential clearance of R- and S-warfarin with the involvement of several polymorphic CYP450 enzymes resulting in the formation of several stereoisomeric oxidative metabolites.

RESULTS: A stereospecific 2DLC/Q-TOF method was developed for the simultaneous identification and quantitation of hydroxylated warfarin metabolites from a single sample analysis. Using this method metabolites from rat microsomal and plated hepatocyte incubations with R-, S- and (R/S)-warfarin were estimated.

CONCLUSION: Multiheart cutting with high resolution MS and MS/MS analysis is suggested as a viable approach for achiral-chiral separation of metabolites of warfarin and other chiral or prochiral drugs.

Publication Types